久久午夜影院,国产大鸡巴九色,丰满人妻一区=区三区在线视频53,五月天婷婷激情四射在线观看

    <source id="7npa8"><tr id="7npa8"><dfn id="7npa8"></dfn></tr></source>
    1. 產(chǎn)品中心您現(xiàn)在的位置:首頁(yè) > 產(chǎn)品展示 > > 天然免疫研究產(chǎn)品 > 5'ppp-dsRNA

      5'ppp-dsRNA

      更新時(shí)間:2022-01-29

      簡(jiǎn)要描述:

      5’ triphosphate double-stranded RNA (5’ppp-dsRNA) is a synthetic ligand for the retinoic acid-inducible protein I (RIG-I, also known as Ddx58). RIG-I is a cytoplasmic RNA helicase that belongs to the…

      型號(hào):廠商性質(zhì):代理商瀏覽量:1818

      RIG-I agonist

      5’ triphosphate double-stranded RNA (5’ppp-dsRNA) is a synthetic ligand for the retinoic acid-inducible protein I (RIG-I, also known as Ddx58). RIG-I is a cytoplasmic RNA helicase that belongs to the RIG-I-like receptors (RLRs) family and triggers an antiviral immune response by the activation of type-I interferons (IFN-α and -β) [1]. RIG-I detects viral RNAs that exhibit an uncapped 5’-di/triphosphate end and a short blunt-ended double-strand portion, two essential features facilitating discrimination from self-RNAs [2-4].
      To achieve stimulation of RIG-I, 5’ppp-dsRNA must be delivered into the cytoplasm, for example by using a transfection agent, such as LyoVec™.

       

      Key features of 5'ppp-dsRNA:

      • 5'ppp-dsRNA is a specific RIG-I agonist.

      • Its biological activity has been verified using our RLR reporter cell lines.

      • For your convenience, pre-complexed 5'ppp-dsRNA/ LyoVec™ is also available.


      References:

      1. Yoneyama M. & Fujita T. , 2007. Function of RIG-I-like Receptors in Antiviral Innate Immunity. J. Biol. Chem. 282:15315-8.
      2. Schlee M. et al., 2009. Recognition of 5’ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in pandhandle of negative-strand virus. Immunity. 17;31(1):25-34.
      3. Schmidt A. et al., 2009. 5’-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. PNAS 106(29):12067-72.
      4. Schlee M. & Hartmann G., 2010. The chase for the RIG-I ligand - recent advances. Mol Ther. 18(7):1254-62.

      Figures

      Specifications

      Specificity: RIG-I agonist

      Sequence:
      5’- pppGCAUGCGACCUCUGUUUGA -3’ (19 mer)
               3’- CGUACGCUGGAGACAAACU -5’ (19 mer)

      Formulation: Naked or pre-complexed with LyoVec™

      Working Concentrations:

      • 300 ng- 1 μg/ml for Naked 5'ppp-dsRNA

      • 1-10 µg/ml for pre-complexed 5'ppp-dsRNA/LyoVec™

      Solubility:

      • 0.1 mg/ml in water for Naked 5'ppp-dsRNA

      • 50 µg/ml in water for pre-complexed 5'ppp-dsRNA/LyoVec™

      Quality Control:

      • The biological activity has been verified using cellular assays.

      • The absence of bacterial contamination (lipoproteins and endotoxins) has been confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cells.


      Contents

      5’ppp-dsRNA Naked is available in two quantities:

      tlrl-3prna:

      • 25 μg 5’ppp-dsRNA naked.

      • 2 ml sterile endotoxin-free water.

      tlrl-3prna-100:

      • 4 x 25 μg 5’ppp-dsRNA naked.

      • 10 ml sterile endotoxin-free water.

       

      5’ppp-dsRNA/LyoVec™ is available in two quantities:

      tlrl-3prnalv:

      • 25 μg 5’ppp-dsRNA complexed with 50 µg of LyoVec™

      • 2 ml sterile endotoxin-free water

      tlrl-3prnalv-100:

      • 4 x 25 μg 5’ppp-dsRNA complexed with 50 µg of LyoVec™

      • 10 ml sterile endotoxin-free water

       

       5’ppp-dsRNA and  5’ppp-dsRNA/LyoVec™ are provided lyophilized and shipped at room temperature.

       Store lyophilized 5’ppp-dsRNA and  5’ppp-dsRNA/LyoVec™ at -20°C.

       Lyophilized product is stable for 1 year when stored -20°C.


      如需購(gòu)買或咨詢?cè)摦a(chǎn)品技術(shù)問(wèn)題,請(qǐng)聯(lián)系Invivogen一級(jí)代理商--欣博盛生物


      留言框

      • 產(chǎn)品:

      • 您的單位:

      • 您的姓名:

      • 聯(lián)系電話:

      • 常用郵箱:

      • 省份:

      • 詳細(xì)地址:

      • 補(bǔ)充說(shuō)明:

      • 驗(yàn)證碼:

        請(qǐng)輸入計(jì)算結(jié)果(填寫(xiě)阿拉伯?dāng)?shù)字),如:三加四=7

      上一篇:AddaS03™

      下一篇:2’3’-cGAMP

      返回列表>>